Pediatric medical devices: a look at significant US legislation to address unmet needs

Joy H Samuels-Reid1, Erica D Blake

  • 1Center for Devices & Radiological Health, US Food & Drug Administration, 10903 New Hampshire Ave WO 66 - 2608, Silver Spring, MD, 20993 USA.

Insights

Legislative actions in the USA aim to overcome barriers in pediatric medical device development. These laws promote safe and effective devices for children, addressing critical unmet needs.

Area of Science:

  • Medical device regulation
  • Pediatric healthcare innovation
  • Health policy and legislation

Background:

  • Significant barriers exist in developing and accessing medical devices for pediatric populations.
  • Healthcare providers often resort to unconventional methods to meet pediatric device needs.

Purpose of the Study:

  • To examine legislative efforts in the USA aimed at improving pediatric medical device availability.
  • To understand how policy changes address unmet needs in pediatric subpopulations.

Main Methods:

  • Review of key US legislation impacting pediatric medical device development.
  • Analysis of provisions promoting pediatric device safety and clinical trial protection.

Main Results:

  • The Medical Device User Fee and Modernization Act of 2002 introduced provisions for pediatric device development and trial safety.
  • The Medical Devices Technical Corrections Act of 2004 aimed to ease market entry for pediatric devices.
  • The Pediatric Medical Device Safety and Improvement Act of 2007 and FDA Amendments Act of 2007 expanded FDA's role in pediatric device oversight.

Conclusions:

  • US legislation has proactively addressed challenges in pediatric medical device availability.
  • These laws aim to ensure the development of safe, effective devices and protect children in clinical research.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K